# Black Diamond Therapeutics, Inc.: Form 8-K, filed Sep 29, 2020

- Company: [Black Diamond Therapeutics, Inc.](/companies/bdtx.md) (CIK 1701541)
- Form: 8-K
- Filed: 2020-09-29
- Accepted by EDGAR: Sep 29, 2020, 08:06 ET
- Period: 2020-09-25
- Accession: 0001193125-20-257227
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1701541/000119312520257227/d829624d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701541/000119312520257227/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701541/000119312520257227/d829624d8k.htm

Filed Sep 29, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-257227. Last ingested by Listed: Nov 10, 2026, 16:37 ET. No prices; not investment advice.
